Device Trial Radar · NCT05462145
Safety and Effectiveness of the Globe® Pulsed Field System for Treating Patients With Symptomatic Paroxysmal or Persistent Atrial Fibrillation
Last checked: Nov 19, 2026Latest source record: Oct 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
549
Planned (sponsor's estimate)
Start
Mar 9, 2023
Primary completion
Mar 2029
Study completion Mar 2029
Sponsor
- Lead sponsor
- Kardium Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Jul 18, 2022
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study will evaluate the safety and effectiveness of the Globe® Pulsed Field System for treating patients with symptomatic paroxysmal or persistent atrial fibrillation (AF).
Conditions
- Paroxysmal Atrial Fibrillation
- Persistent Atrial Fibrillation
Interventions
Globe Pulsed Field SystemDevice
Ablation and atrial mapping with the Globe Pulsed Field System
Primary outcomes
What the sponsor says the trial is designed to measure.
- Effectiveness endpointTime frame: 12 months
- Safety endpointTime frame: 7 days
Locations
17 sites in 4 countries. Site status is shown where the registry gives one.
Grandview Medical Center
Birmingham, Alabama
St. Bernards Medical Center
Jonesboro, Arkansas
Sutter Health - California Pacific Medical Center
San Francisco, California
14 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.